Cap displayed in your preferred currency (USD)
Industries & Sectors
| Description | Symbol | Type | #Stocks | Cap (M) | 1Day %* | 1Wk %* | 1Mo %* | 3Mo %* | 6Mo %* | 1Yr %* |
|---|---|---|---|---|---|---|---|---|---|---|
| United States (Primary) | PRIMARYUSA | Univ | 6,167 | 71,392,131 | -0.06% | 1.02% | 3.28% | 9.74% | 16.34% | 17.32% |
| Healthcare | HEALTHCARE | Sector | 1,171 | 6,419,631 | 0.14% | -0.11% | 0.77% | 4.75% | -2.38% | -8.26% |
| Biopharmaceuticals | BIOPHARMA | SubSec | 599 | 3,219,771 | 0.28% | 0.20% | 2.34% | 8.20% | 0.92% | -6.48% |
| System-Specific Biopharmaceuticals | BIOPHARMASYS | Industry | 283 | 1,240,561 | -0.36% | 0.23% | 6.17% | 4.03% | -3.53% | -10.07% |
| Neurology Biopharmaceuticals | NEUROLOGY | SubInd | 90 | 99,539 | 0.94% | 0.48% | 4.52% | 13.85% | 0.98% | -8.85% |
Show Stocks
Sort: 1Mo %
| Description | Symbol | Type | #Stocks | Cap (M) | 1Day %* | 1Wk %* | 1Mo %* | 3Mo %* | 6Mo %* | 1Yr %* |
|---|---|---|---|---|---|---|---|---|---|---|
| Dianthus Therapeutics, Inc. | DNTH:USADNTH:USA | Stock | 1 | 1,251 | 3.76% | 2.59% | 85.50% | 122.94% | 88.83% | 47.16% |
| Rapport Therapeutics, Inc. | RAPP:USARAPP:USA | Stock | 1 | 960 | 0.42% | 17.41% | 80.26% | 138.44% | 168.92% | 39.97% |
| Stoke Therapeutics, Inc. | STOK:USASTOK:USA | Stock | 1 | 1,244 | -1.81% | 0.35% | 22.85% | 96.54% | 175.30% | 54.48% |
| PTC Therapeutics, Inc. | PTCT:USAPTCT:USA | Stock | 1 | 4,814 | 1.61% | 3.98% | 21.79% | 20.27% | 6.44% | 79.60% |
| ATAI Life Sciences NV | ATAI:USAATAI:USA | Stock | 1 | 978 | -0.86% | -2.33% | 13.83% | 97.85% | 231.65% | 265.87% |
| Jazz Pharmaceuticals Plc | JAZZ:USAJAZZ:USA | Stock | 1 | 7,855 | 2.37% | 2.08% | 10.09% | 19.68% | -8.82% | 18.23% |
| Neurocrine Biosciences, Inc. | NBIX:USANBIX:USA | Stock | 1 | 14,130 | 1.30% | 1.05% | 7.20% | 12.11% | 29.39% | 16.75% |
| Dyne Therapeutics, Inc. | DYN:USADYN:USA | Stock | 1 | 1,504 | 1.23% | -0.98% | 6.65% | 21.99% | 6.05% | -61.77% |
| Biogen, Inc. | BIIB:USABIIB:USA | Stock | 1 | 21,238 | 0.83% | 1.58% | 6.59% | 14.49% | 2.43% | -27.41% |
| Axsome Therapeutics, Inc. | AXSM:USAAXSM:USA | Stock | 1 | 5,809 | 2.21% | -6.04% | 4.94% | 13.34% | -7.37% | 26.20% |
| Neurology Biopharmaceuticals | NEUROLOGY | SubInd | 90 | 99,539 | 0.94% | 0.48% | 4.52% | 13.85% | 0.98% | -8.85% |
| Supernus Pharmaceuticals, Inc. | SUPN:USASUPN:USA | Stock | 1 | 2,514 | 1.84% | -3.05% | 4.21% | 35.92% | 39.87% | 42.31% |
| S&P 500 | SPY:USASPY:USA | Benchmark | 14,158 | 94,381,925 | -0.12% | 1.07% | 2.47% | 10.66% | 16.93% | 18.58% |
| Scholar Rock Holding Corp. | SRRK:USASRRK:USA | Stock | 1 | 3,067 | -1.21% | 2.27% | 1.36% | -12.03% | -5.95% | 294.44% |
| Edgewise Therapeutics, Inc. | EWTX:USAEWTX:USA | Stock | 1 | 1,463 | -1.21% | -5.32% | -0.79% | -4.01% | -43.51% | -17.62% |
| Alkermes Plc | ALKS:USAALKS:USA | Stock | 1 | 4,600 | 1.75% | 3.49% | -0.87% | -4.98% | -18.84% | 0.14% |
| Taysha Gene Therapies, Inc. | TSHA:USATSHA:USA | Stock | 1 | 791 | 2.11% | -10.77% | -1.02% | 12.84% | 58.47% | 33.64% |
| Catalyst Pharmaceuticals, Inc. | CPRX:USACPRX:USA | Stock | 1 | 2,450 | -0.25% | 1.42% | -1.04% | -12.23% | -11.42% | -2.05% |
| GH Research PLC | GHRS:USAGHRS:USA | Stock | 1 | 775 | -1.03% | -3.03% | -1.34% | 5.57% | 5.40% | 51.88% |
| Mind Medicine (MindMed), Inc. | MNMD:USAMNMD:USA | Stock | 1 | 725 | -1.44% | 2.57% | -1.85% | 34.98% | 42.84% | 50.47% |
| Xenon Pharmaceuticals, Inc. | XENE:USAXENE:USA | Stock | 1 | 2,824 | 2.92% | -1.10% | -2.96% | 15.05% | 5.04% | -8.20% |
| ACADIA Pharmaceuticals, Inc. | ACAD:USAACAD:USA | Stock | 1 | 4,080 | 1.00% | 1.68% | -3.43% | 5.45% | 39.97% | 49.94% |
| Praxis Precision Medicines, Inc. | PRAX:USAPRAX:USA | Stock | 1 | 926 | 4.83% | 9.45% | -5.58% | 2.47% | 14.01% | -24.46% |
| Biohaven Ltd. | BHVN:USABHVN:USA | Stock | 1 | 1,555 | 8.97% | 4.93% | -8.18% | 2.15% | -48.87% | -62.33% |
| Anavex Life Sciences Corp. | AVXL:USAAVXL:USA | Stock | 1 | 750 | -2.01% | -1.07% | -8.45% | -2.77% | -10.77% | 54.04% |
| Denali Therapeutics, Inc. | DNLI:USADNLI:USA | Stock | 1 | 1,903 | -1.51% | -10.79% | -11.88% | -7.31% | -11.88% | -56.94% |
| Harmony Biosciences Holdings, Inc. | HRMY:USAHRMY:USA | Stock | 1 | 1,845 | -0.71% | -3.46% | -11.95% | -1.29% | -6.80% | -17.29% |
| Sarepta Therapeutics, Inc. | SRPT:USASRPT:USA | Stock | 1 | 1,666 | -5.80% | -0.99% | -18.77% | -17.91% | -78.68% | -86.29% |
* Colors indicate performance relative to the benchmark.